BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+12.16%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$717M
AUM Growth
–
Cap. Flow
+$717M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
141
New
140
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Biogen
BIIB
|
$29.9M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$26M |
| 4 |
Abbott
ABT
|
$23.5M |
| 5 |
Gilead Sciences
GILD
|
$22.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.27% |
| 2 | Financials | 0.88% |
| 3 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCR
51
DELISTED
CR Bard Inc.
BCR
| $5.02M | 0.7% |
+30,000
| New | +$5.02M |
|
|
CERN
52
DELISTED
Cerner Corp
CERN
| $4.84M | 0.67% |
+66,000
| New | +$4.84M |
|
53
Elevance Health
ELV
$71.8B
| $4.63M | 0.65% |
+30,000
| New | +$4.63M |
|
54
Humana
HUM
$36.5B
| $4.45M | 0.62% |
+25,000
| New | +$4.45M |
|
|
VAR
55
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.42M | 0.62% |
+47,000
| New | +$4.42M |
|
|
ACHN
56
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $4.4M | 0.61% |
+446,000
| New | +$4.4M |
|
|
ARIA
57
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $4.36M | 0.61% |
+529,000
| New | +$4.36M |
|
58
Novavax
NVAX
$1.21B
| $4.3M | 0.6% |
+520,000
| New | +$4.3M |
|
59
Johnson & Johnson
JNJ
$427B
| $4.02M | 0.56% |
+40,000
| New | +$4.02M |
|
60
Bristol-Myers Squibb
BMY
$96B
| $3.87M | 0.54% |
+60,000
| New | +$3.87M |
|
61
Community Health Systems
CYH
$387M
| $3.66M | 0.51% |
+70,000
| New | +$3.66M |
|
62
Teleflex
TFX
$5.59B
| $3.63M | 0.51% |
+30,000
| New | +$3.63M |
|
63
Cooper Companies
COO
$13.4B
| $3.47M | 0.48% |
+18,500
| New | +$3.47M |
|
|
CLVS
64
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.13M | 0.44% |
+42,100
| New | +$3.13M |
|
65
CVS Health
CVS
$92.8B
| $3.1M | 0.43% |
+30,000
| New | +$3.1M |
|
|
SRCL
66
DELISTED
Stericycle Inc
SRCL
| $2.95M | 0.41% |
+21,000
| New | +$2.95M |
|
67
Hologic
HOLX
$14.9B
| $2.68M | 0.37% |
+81,000
| New | +$2.68M |
|
|
SHPG
68
DELISTED
Shire pic
SHPG
| $2.63M | 0.37% |
+11,000
| New | +$2.63M |
|
69
Celldex Therapeutics
CLDX
$1.47B
| $2.61M | 0.36% |
+104,000
| New | +$2.61M |
|
70
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
| $2.59M | 0.36% |
+75,000
| New | +$2.59M |
|
71
Tenet Healthcare
THC
$16.3B
| $2.48M | 0.35% |
+50,000
| New | +$2.48M |
|
72
Inovio Pharmaceuticals
INO
$126M
| $2.45M | 0.34% |
+300,000
| New | +$2.45M |
|
73
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.45M | 0.34% |
+80,000
| New | +$2.45M |
|
74
Perrigo
PRGO
$3.27B
| $2.33M | 0.33% |
+15,000
| New | +$2.33M |
|
|
SGNT
75
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.33M | 0.32% |
+100,000
| New | +$2.33M |
|